Cargando…
Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma
Rationale: Hepatocellular carcinoma (HCC) is primarily characterized by a high incidence of vascular invasion. However, the specific mechanism underlying portal vein tumor thrombus (PVTT) in HCC remains unclear. As a consequence of myeloid cell developmental arrest, CD71(+) erythroid progenitor cell...
Autores principales: | Zhu, Wei-Hang, Chen, Jie, Huang, Run-Kai, Zhang, Yuan, Huang, Ze-Xuan, Pang, Xiu-Qing, Hu, Bo, Yang, Yang, Li, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465220/ https://www.ncbi.nlm.nih.gov/pubmed/37649603 http://dx.doi.org/10.7150/thno.82907 |
Ejemplares similares
-
Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
por: Kamiyama, Toshiya, et al.
Publicado: (2017) -
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
por: Deng, Zhu-Jian, et al.
Publicado: (2022) -
Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yang, Biao, et al.
Publicado: (2016) -
Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
por: Sun, Ju-Xian, et al.
Publicado: (2016) -
Spontaneous Regression of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Koya, Yudai, et al.
Publicado: (2018)